Skip to main content
ROSSARI BIOTECH LIMITED logo

ROSSARI BIOTECH LIMITED — Investor Relations & Filings

Ticker · ROSSARI ISIN · INE02A801020 LEI · 335800R7XFRR8ZTHBQ25 BSE.NS Manufacturing
Open in API
Filings indexed 527 across all filing types
Latest filing 2024-10-21 Regulatory Filings
Country IN India
Listing BSE.NS ROSSARI

About ROSSARI BIOTECH LIMITED

https://www.rossari.com/

Rossari Biotech Limited is a specialty chemicals manufacturer focused on providing sustainable and innovative solutions across diverse sectors. The company operates through three primary business segments: Home, Personal Care and Performance Chemicals (HPPC), Textile Specialty Chemicals, and Animal Health and Nutrition. In the HPPC segment, it supplies essential ingredients for detergents, soaps, paints, and water treatment applications. Its textile division offers a comprehensive range of chemicals for the entire textile value chain, including pre-treatment, dyeing, and finishing processes. Additionally, the company provides high-quality feed additives and supplements for the poultry and livestock industries. Driven by robust research and development capabilities, Rossari Biotech emphasizes eco-friendly chemistry and customized formulations to meet specific client requirements. With advanced manufacturing facilities, the company serves a global clientele, maintaining a strong focus on operational excellence.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Regulatory Filings
2024-10-21 English
Investor Presentation
Regulatory Filings
2024-10-20 English
Press Release
Earnings Release Classification · 95% confidence The document is a press release dated October 20, 2024, announcing the financial results for the quarter and half year ended September 30, 2024 (Q2 FY25). It includes key financial metrics such as revenue, EBITDA, PAT, and EPS, along with management commentary on performance and business developments. The document also mentions corporate actions like subsidiary incorporation, acquisition plans, land purchase, and a new director appointment. The content is typical of an Earnings Release, which provides initial quarterly financial results and highlights. The document length (10,497 characters) and detailed financial data confirm it is not merely an announcement or a brief summary but a full earnings release. Therefore, the appropriate classification is Earnings Release (ER). Q2 2025
2024-10-20 English
Investor Presentation
Regulatory Filings
2024-10-20 English
Updates
Share Issue/Capital Change Classification · 95% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) regarding the allotment of equity shares under the company's Employee Stock Option Plan (ESOP) 2019. It references regulatory compliance under SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, and provides detailed disclosure information about the share allotment, including number of shares, exercise price, premium, and share capital changes. The document is a notification of a capital change event (allotment of shares) rather than a financial report or earnings release. It does not contain financial statements or management discussion but is an announcement of a share capital change due to ESOP exercise. Therefore, the appropriate classification is Share Issue/Capital Change (SHA). The document length is 4556 characters, which is sufficient for a detailed announcement but not a full report. Confidence is high due to clear references to share allotment and capital increase.
2024-10-19 English
Shareholders meeting
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Notice convening an Extraordinary General Meeting (EGM) of Rossari Biotech Limited scheduled for November 11, 2024. It includes details about the meeting, the agenda items (appointment and re-appointment of independent directors), compliance with SEBI and MCA regulations, and instructions for e-voting. The document is a formal notice to shareholders about the meeting and does not contain financial statements, audit information, or detailed management discussion. It is not a report but a meeting notice. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings such as EGMs.
2024-10-19 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.